Jill Leversage

Insider Reports History

Identity 1 identity field
Location
Victoria, British Columbia, Canada
SEC source record 1 source field
Owner filing signature
/s/ Jill Leversage
Source evidence 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jill Leversage

Form 4 holding Director

Aurinia Pharmaceuticals Inc.

Security class
Director Stock Option (right to buy)
Shares / value
18,641
Estimated value
Report date
21 Nov 2024
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount

Insider Reports Filed by Jill Leversage

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .